These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

730 related items for PubMed ID: 7539044

  • 1. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 2. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
    Levitsky V, Zhang QJ, Levitskaya J, Masucci MG.
    J Exp Med; 1996 Mar 01; 183(3):915-26. PubMed ID: 8642295
    [Abstract] [Full Text] [Related]

  • 3. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ.
    J Exp Med; 1992 Jul 01; 176(1):169-76. PubMed ID: 1377222
    [Abstract] [Full Text] [Related]

  • 4. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.
    Misko IS, Schmidt C, Honeyman M, Soszynski TD, Sculley TB, Burrows SR, Moss DJ, Burman K.
    Clin Exp Immunol; 1992 Jan 01; 87(1):65-70. PubMed ID: 1370774
    [Abstract] [Full Text] [Related]

  • 5. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
    Murray RJ, Kurilla MG, Griffin HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E.
    Proc Natl Acad Sci U S A; 1990 Apr 01; 87(8):2906-10. PubMed ID: 2158098
    [Abstract] [Full Text] [Related]

  • 6. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR.
    Eur J Immunol; 1995 May 01; 25(5):1374-84. PubMed ID: 7774641
    [Abstract] [Full Text] [Related]

  • 7. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
    Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB.
    J Exp Med; 1992 Jul 01; 176(1):157-68. PubMed ID: 1319456
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.
    Misko IS, Schmidt C, Moss DJ, Burrows SR, Sculley TB.
    J Gen Virol; 1991 Feb 01; 72 ( Pt 2)():405-9. PubMed ID: 1704413
    [Abstract] [Full Text] [Related]

  • 9. Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses to Epstein-Barr virus in children.
    Tamaki H, Beaulieu BL, Somasundaran M, Sullivan JL.
    J Infect Dis; 1995 Sep 01; 172(3):739-46. PubMed ID: 7658067
    [Abstract] [Full Text] [Related]

  • 10. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.
    Int Immunol; 1992 Nov 01; 4(11):1283-92. PubMed ID: 1282031
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M, Benninger-Döring G, Prang N, Sylla BS, Laumbacher B, Wank R, Wolf H, Schwarzmann F.
    Int J Cancer; 1998 May 29; 76(5):694-701. PubMed ID: 9610728
    [Abstract] [Full Text] [Related]

  • 12. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component.
    Misko IS, Sculley TB, Schmidt C, Moss DJ, Soszynski T, Burman K.
    Cell Immunol; 1991 Feb 29; 132(2):295-307. PubMed ID: 1846323
    [Abstract] [Full Text] [Related]

  • 13. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
    Brooks JM, Murray RJ, Thomas WA, Kurilla MG, Rickinson AB.
    J Exp Med; 1993 Sep 01; 178(3):879-87. PubMed ID: 7688791
    [Abstract] [Full Text] [Related]

  • 14. Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.
    Reali E, Guerrini R, Giori B, Borghi M, Marastoni M, Tomatis R, Traniello S, Masucci MG, Gavioli R.
    Clin Exp Immunol; 1996 Aug 01; 105(2):369-75. PubMed ID: 8706347
    [Abstract] [Full Text] [Related]

  • 15. A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.
    Morgan SM, Wilkinson GW, Floettmann E, Blake N, Rickinson AB.
    J Virol; 1996 Apr 01; 70(4):2394-402. PubMed ID: 8642667
    [Abstract] [Full Text] [Related]

  • 16. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
    Stuber G, Dillner J, Modrow S, Wolf H, Székely L, Klein G, Klein E.
    Int Immunol; 1995 Apr 01; 7(4):653-63. PubMed ID: 7547693
    [Abstract] [Full Text] [Related]

  • 17. CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells.
    Khanolkar A, Fu Z, Underwood LJ, Bondurant KL, Rochford R, Cannon MJ.
    J Immunol; 2003 Mar 15; 170(6):3187-94. PubMed ID: 12626577
    [Abstract] [Full Text] [Related]

  • 18. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Khanna R, Burrows SR, Steigerwald-Mullen PM, Thomson SA, Kurilla MG, Moss DJ.
    Virology; 1995 Dec 20; 214(2):633-7. PubMed ID: 8553567
    [Abstract] [Full Text] [Related]

  • 19. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
    Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows JM, Moss DJ, Misko IS.
    Int Immunol; 1997 Nov 20; 9(11):1745-55. PubMed ID: 9418135
    [Abstract] [Full Text] [Related]

  • 20. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF, Ladanyi M, Louie DC, Fernandez JM, Papadopoulos EB, O'Reilly RJ.
    J Exp Med; 1996 Mar 01; 183(3):1215-28. PubMed ID: 8642263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.